Project Details
Description
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
| Status | Active |
|---|---|
| Effective start/end date | 4/1/18 → 4/30/26 |
Funding
- ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY
- JANSSEN PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.